Category: Made with LallianSe

April 2024

Very pleased to announce therenewal of our partnership withVoisin Consulting Life Sciences (VCLS) !

Led by Sébastien Giraudier, PhD, #Neighborhood is a support program for 13 health #startups which offers a series of interviews, exchanges and mentoring sessions for 12 months.

For 3 years already, led by Emmanuelle Deponge, a LallianSe Expert, involved in the selection of projects, #NBGH has entrusted us with the 360° Sessions in a format specifically organized to meet the challenges of the program

Last week, the launch of the new #Neighbors promotion was marked by Syntopia, represented by Adrien Rennesson & Philippe Nghe, and TheraSonic represented by Benoit Larrat, PhD & Carsten Laue.

These sessions do not just challenge all of the company’s development areas. They also aim to build the foundations of the #equitystory for the development of business projects!

March 2023

At LallianSe, each support is tailor-made,flexible and agile to meet the key development challenges of our clients and partners, here with NBGH

Initiative launched by Voisin Consulting Life Sciences (VCLS) and led by Sébastien Giraudier, PhD, #Neighborhood is an annual #support program for 12 #health #startups which offers a series of interviews, support, exchanges and mentoring sessions.

#NBGH asked #LallianSe to pilot the « 360° Sessions » at the instigation of Emmanuelle Deponge, involved in the selection of projects while being #LallianSe Expert for several years.

These sessions challenge all areas of business development: from planning to execution, from regulatory strategy to organization, thanks to LallianSe’s unique track record and Emmanuelle’s #expertise.

April 2024

For the 3rd consecutive year, Julie contributed to the co-design workshops in e-health & rares diseases organized by the Rare Diseases Foundation.

At #LallianSe, our #experience in constructing investment theses allows us to highlight the most relevant dimensions and milestones of each project, thus providing necessary insight and value creation for investors.

We are delighted to see the ‘SCLER-AIME’ project led by Cloé Comarmond, internist at the Lariboisière hospital of the #APHP designated #winner with support of €5,000 from the participants alongside Julie Rachline : Alice PARNEL • Marie-Christine Jaulent • Elise L.

Thanks to the Foundation team for contacting us again: Dr Pierre Espinoza, Gaëlle Dombu Smeets & Pascale Milani.

Julie Rachline, Pascale Maisonneuve, Shahrzad Moradi Eve Le Bail Théo Pezel Damien Sène Stéphane Mouly

---

April 2023

Remember, we announced to you at the beginning of the year the renewal of our #collaboration with the Rare Diseases Foundation as part of the co-design workshops in e-health & rare diseases for projects in the early study phase.

What are the objectives of these workshops?

🎯  Help in the initiation of innovative projects by identifying the necessary resources and key steps for their implementation
🎯 Adopt a collaborative approach and stimulate inter-business dialogue from the first ideas
🎯 Promote discussions with partners and Experts who master the subject

Why is this important to us?

💪 To encourage the emergence of innovations driven by healthcare professionals
🙌 To support the improvement of the care and life path of people suffering from a rare disease
🤝 To be consistent with our values and our field initiatives

It is as a LallianSe Expert that Julie Rachline was able to bring her #expertise to the ‘Brain Mouv’ project led by Iris Marolleau.

Thanks to the Experts : Charlotte Douard, Samuel Pouplin, Ariane David & Sandrine Hudson Pradier as well as the Foundation team: Céline Bordet, pierre espinoza, Gaëlle Dombu Smeets & Pascale Milani.

For almost 4 years now, the relationship driven by Bpifrance Le Hub betweenFab’entech and LallianSe – Life Sciences Integrator has been enriched and developed.

Initiated as #SparringPartner following the arrival of Sébastien IVA as Chairman of the Management Board in 2020, the translation of the vision, the outline of the roadmap and the articulation of the investment thesis have gradually strengthened the agenda of interactions and existing support.

A real pleasure to support the evolution of #Fabentech towards its position as European leader!

Discover all of our feedback here 👉 link to the interview

January 2024

A few months ago, in one of the last DYSL Pierre-Emmanuel Gerard, presented the key issues of BIOMUNEX PHARMACEUTICALS.

Very happy to share today this excellente news for the development of #Biomunex.

For more than 5 years, with one of our key Expert-in-Residence, Stéphane MILOT, with Loïc MOULARD also for a few months, at the helm of the outsourced Financial Department, as well as our support around different strategic and operational perspectives, #LallianSe is pleased to contribute to the success of Biomunex.

Congratulations to the entire team for starting this clinical study ! 👏

Find out more👉 https://lnkd.in/eH47-xeJ

#Partnership #innovation #biotech #healthcare #immunotherapy #XIR